Immediate Impact
1 by Nobel laureates 38 from Science/Nature 54 standout
Citing Papers
Antisense oligonucleotide therapeutic approach for Timothy syndrome
2024 StandoutNature
Y chromosome loss in cancer drives growth by evasion of adaptive immunity
2023 StandoutNature
Works of Paul Elvin being referenced
A phase I dose escalation, safety and pharmacokinetic (PK) study of AZD5312 (IONIS-ARRx), a first-in-class Generation 2.5 antisense oligonucleotide targeting the androgen receptor (AR)
2016
Regional copy number–independent deregulation of transcription in cancer
2006
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Paul Elvin | 724 | 389 | 146 | 228 | 47 | 1.3k | |
| Yasushi Saga | 662 | 349 | 114 | 249 | 64 | 1.3k | |
| Steven A. Enkemann | 775 | 411 | 120 | 244 | 31 | 1.2k | |
| Kang–Da Liu | 598 | 299 | 111 | 327 | 41 | 1.2k | |
| Dorina Gui | 848 | 335 | 163 | 240 | 50 | 1.7k | |
| Miguel Aracil | 673 | 345 | 105 | 260 | 41 | 1.3k | |
| Orlando Musso | 788 | 423 | 146 | 465 | 39 | 1.6k | |
| Felix Bachmann | 794 | 336 | 73 | 204 | 59 | 1.7k | |
| Shunsuke Yanoma | 410 | 487 | 172 | 313 | 53 | 1.2k | |
| Makiko Kawaguchi | 550 | 308 | 68 | 193 | 69 | 1.3k | |
| Lakjaya Buluwela | 926 | 431 | 116 | 225 | 28 | 1.6k |
All Works
Loading papers...